Truist Financial Corp acquired a new stake in shares of Mirion Technologies, Inc. (NYSE:MIR – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,890 shares of the company’s stock, valued at approximately $104,000.
Other hedge funds have also recently modified their holdings of the company. Exos Asset Management LLC purchased a new position in Mirion Technologies during the 4th quarter valued at about $163,000. Victory Capital Management Inc. purchased a new position in shares of Mirion Technologies during the fourth quarter valued at approximately $206,000. FDx Advisors Inc. purchased a new stake in shares of Mirion Technologies in the 4th quarter worth approximately $277,000. HighTower Advisors LLC bought a new position in shares of Mirion Technologies during the fourth quarter valued at $345,000. Finally, Shay Capital LLC purchased a new position in shares of Mirion Technologies in the 4th quarter worth about $356,000. Institutional investors own 78.79% of the company’s stock.
Mirion Technologies Stock Up 5.8 %
MIR stock opened at $6.80 on Monday. The company has a quick ratio of 1.47, a current ratio of 2.05 and a debt-to-equity ratio of 0.46. The business’s 50-day moving average price is $6.72 and its 200-day moving average price is $7.60. Mirion Technologies, Inc. has a twelve month low of $5.40 and a twelve month high of $11.95.
Analyst Ratings Changes
Separately, The Goldman Sachs Group dropped their target price on shares of Mirion Technologies from $12.00 to $9.00 and set a “buy” rating on the stock in a research note on Thursday, June 23rd.
Mirion Technologies Company Profile
Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products.
Recommended Stories
- Get a free copy of the StockNews.com research report on Mirion Technologies (MIR)
- Use These To Find Your Stock’s Support and Resistance Levels
- Is Boeing Stock is Ready for Lift-Off ?
- Elon Musk is Out, But Should You Be In Twitter Stock?
- 3 Earnings Announcements That Could Surprise
- Twitter’s Up For Third Week In A Row: What’s Next For The Stock?
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.